Success Metrics

Clinical Success Rate
83.3%

Based on 10 completed trials

Completion Rate
83%(10/12)
Active Trials
3(20%)
Results Posted
10%(1 trials)
Terminated
2(13%)

Phase Distribution

Ph phase_1
11
73%
Ph phase_3
1
7%
Ph phase_2
3
20%

Phase Distribution

11

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
11(73.3%)
Phase 2Efficacy & side effects
3(20.0%)
Phase 3Large-scale testing
1(6.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

10 of 12 finished

Non-Completion Rate

16.7%

2 ended early

Currently Active

3

trials recruiting

Total Trials

15

all time

Status Distribution
Active(3)
Completed(10)
Terminated(2)

Detailed Status

Completed10
Terminated2
Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
3
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 111 (73.3%)
Phase 23 (20.0%)
Phase 31 (6.7%)

Trials by Status

terminated213%
active_not_recruiting17%
completed1067%
recruiting213%

Recent Activity

3 active trials
Showing 5 of 15
recruitingphase_1

A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver Problems

NCT07023354
recruitingphase_3

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

NCT06872892
active_not_recruitingphase_2

Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine

NCT05846230
completedphase_2

A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™)

NCT05865886
completedphase_1

A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the Blood

NCT06917872
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT07023354Phase 1

A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver Problems

Recruiting
NCT06872892Phase 3

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

Recruiting
NCT05846230Phase 2

Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine

Active Not Recruiting
NCT05865886Phase 2

A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™)

Completed
NCT06917872Phase 1

A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the Blood

Completed
NCT05238675Phase 2

A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis

Completed
NCT04866160Phase 1

A Trial in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated

Completed
NCT06166992Phase 1

A Study in Healthy Men to Test How BI 1291583 is Taken up by the Body

Completed
NCT03890887Phase 1

A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1291583 in the Blood

Completed
NCT03414008Phase 1

This Study Tests How Different Doses of BI 1291583 Are Taken up in the Body and How Well They Are Tolerated

Terminated
NCT03868540Phase 1

A Study in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated

Terminated
NCT05183347Phase 1

A Study in Healthy Japanese Men to Test How Well Different Doses of BI 1291583 Are Tolerated

Completed
NCT06631417Phase 1

A Study in Healthy People to Test How 2 Different Doses of BI 1291583 Are Taken up in the Body When Given in 3 Different Formulations

Completed
NCT03837964Phase 1

A Study to Test How Food Influences the Amount of BI 1291583 in the Blood of Healthy Men

Completed
NCT06791187Phase 1

A Study in Healthy People to Test Whether BI 1291583 Influences the Amount of Dabigatran in the Body

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15